An alum of the Hahnemann Medical College and the Medical College of Pennsylvania is named a Distinguished Life Fellow of the American Psychiatric Association; and an area artist celebrates her 100th birthday with an exhibit of her works at Rosemont College.
An alum of Hahnemann Medical College and the Medical College of Pennsylvania, Dr. Ronald A. Krisch of Allentown, a psychiatrist with expertise in serving children and adolescents for some 40 years, has been honored as a Distinguished Life Fellow by the American Psychiatric Association, the highest accolade of his profession. The honor will be accorded officially in May at the 2015 Convocation of Distinguished Fellows to be held when the American Psychiatric Association holds its annual confab in Toronto.
Artist Frieda Lefeber is celebrating her 100th birthday with an exhibit of her work, “Her Life and Her Art,” currently being shown at Rosemont College’s Lawrence Gallery. The show celebrates her victories in life, including fleeing the Holocaust, settlement in this country and graduation from the Pennsylvania Academy of the Fine Arts at age 83.
Susan Gittlen of Whispering Woods Gallery in Holland, Pa., has taken top honor in the custom-framed textiles category of the third annual Larson-Juhl Design Star: Framing Edition competition, heralded as the most prominent of its kind, held in Las Vegas. Gittlen’s first-place piece was for framing a blackwork stitchery work.
Pearl Siegel has been proclaimed winner of the hamantashen-baking contest held by the Newtown Group of Hadassah, which cited its 96-year-old member’s use of a marble rolling pin as giving the pastries a delicious edge.
The Gershman Y of Center City and the National Museum of American Jewish History, located in Old City, have been named winners of grants from the Philadelphia Cultural Fund.
Walter J. Koch, Ph.D., the William Wikoff Smith Endowed Chair in Cardiovascular Medicine and director of the Center for Translational Medicine at Temple University School of Medicine, captained a team of researchers in discovering that Paxil, a commonly distributed anti-depressant, was able to reverse the impact of heart failure. The trials, with mice as subjects, are reported in the March 4 edition of Science Translational Medicine.
